Pages that link to "Q45299354"
Jump to navigation
Jump to search
The following pages link to Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models. (Q45299354):
Displaying 19 items.
- Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease. (Q38746156) (← links)
- Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain. (Q45305673) (← links)
- Clinical Trials Corner: September 2017. (Q47123763) (← links)
- Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases (Q47301376) (← links)
- Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease. (Q52676144) (← links)
- Striatal Direct and Indirect Pathway Output Structures are Differentially Altered in Mouse Models of Huntington's Disease. (Q52691798) (← links)
- Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies. (Q54965657) (← links)
- Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas (Q57021540) (← links)
- MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's disease (Q58549346) (← links)
- Therapeutic approaches to Huntington disease: from the bench to the clinic (Q64859904) (← links)
- Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1 (Q88514636) (← links)
- Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms (Q89285568) (← links)
- Methylxanthines: Potential Therapeutic Agents for Glioblastoma (Q89995883) (← links)
- Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models (Q90140618) (← links)
- Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond (Q92461195) (← links)
- Targeting Phosphodiesterases-Towards a Tailor-Made Approach in Multiple Sclerosis Treatment (Q92511375) (← links)
- The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges (Q95650650) (← links)
- Large Animal Models of Huntington's Disease: What We Have Learned and Where We Need to Go Next (Q99410966) (← links)
- Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice (Q99638675) (← links)